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A variety of diseases lead to the atrophy and/or death of skeletal muscle. To better 
understand the molecular mechanisms that mediate these processes, I have taken 
advantage of the intersegmental muscles (ISMs) of the tobacco hawkmoth Manduca 
sexta, which undergo sequential programs of atrophy and programmed cell death at the 
end of metamorphosis. ISM death is mediated by changes in gene expression and 
numerous cell-death associated transcripts have been identified.  MicroRNAs (miRs) are 
small (~22 nucleotide) non-coding RNAs that bind to sequences in messenger RNAs 
(mRNAs) and either cause translational arrest or mRNA degradation.  To test the 
hypothesis that developmentally regulated miRs may control the stability and/or 
translatability of target mRNAs in the ISMs, putative mRNA targets for the test miRs 
have been identified and their 3’ untranslated region (UTR) have been cloned into a dual 
luciferase reporter plasmid. The microRNA mir-92b binds to the 3’ UTR of the Small 
Cytoplasmic Leucine Rich repeat Protein (SCLP) mRNA. Expression of miR-92b 
declines during development and SCLP expression increases with the commitment to 
die. I found that the miR-92b inhibits luciferase mRNA translation (spectrophotometric 
plate assays), but does not lead to transcript degradation (quantitative polymerase chain 
 v 
 
reaction; qPCR). miR-92 plays a survival role in several mammalian tissues and is 
repressed in two types of cardiomyopathy. Consequently, understanding how miRs 
regulate mRNA translation and stability may provide a better understanding of the 
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Introduction 
Skeletal muscle is the largest tissue in the body and serves as its primary 
reservoir of amino acids. During development or following exercise, muscles can 
undergo hypertrophy resulting in increased mass, while starvation and certain disorders 
can result in a net loss of muscle protein, a condition known as atrophy. Some of the 
factors that can induce atrophy include: diabetes, cancer cachexia, motor neuron 
diseases, spinal cord injury, immobility, and aging (Schiaffino et al., 2013). Age-
associated atrophy, known as sarcopenia, is a condition that causes protracted atrophy 
and a decrease in strength in the elderly (Leeuwenburgh and Marzetti, 2006). Sarcopenia 
affects 13-24% of 50 year olds and up to 50% of people over age 80 (Baumgartner et. 
al., 1999). These individuals lose muscle mass at a rate of 1-2% per year, which means 
that they may lose up to 40% of their muscle mass by age 80, resulting in physical 
disabilities, decrease in independence, and increased risk of falls (Hughes et al., 2002; 
Roubenoff, 2000). Sarcopenia takes a major toll on both the quality of life and the 
national economy (Janssen et al, 2004). Despite the prevalence of sarcopenia, there is 
still much to be learned about the regulatory processes that lead to the dramatic decrease 
of muscle mass. Physical inactivity and declines in certain hormones may play roles, 
although the underlying molecular mechanisms are poorly understood (Dirks and 
Leeuwenburgh, 2002; Szulc et al., 2004). 
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Given the slow progression of sarcopenia and many other muscle disorders, it is 
challenging to study skeletal muscle atrophy and muscle fiber cell death in humans. An 
alternative strategy is to utilize a model system where it is easier to identify the 
underlying molecular mechanisms that can inform subsequent clinical studies. One such 
model is the intersegmental muscle (ISM) of the tobacco hawkmoth Manduca sexta 
(Schwartz, 2008). 
Late in metamorphosis the ISMs initiate a program of atrophy that results in a 
40% loss of muscle mass over a three-day period (Schwartz and Truman, 1983).  The 
muscles are then used to eclose (emerge) from the overlying pupal cuticle at the end of 
metamorphosis allowing the moth to escape.  Concurrent with eclosion, the ISMs initiate 
programmed cell death (PCD) and die during the subsequent 30 hours (Lockshin and 
Williams, 1965; Schwartz, 2008). The ISMs have a number of additional properties that 
make them attractive models for the study of atrophy and cell death. Unlike mammalian 
muscles, the ISMs are composed of a single fiber type and lack regenerative muscle 
stem cells (satellite cells), all of which help overcome some of the technical limitations 
that are associated with studying heterogeneous tissues (Schwartz, 2008). 
There are four stages associated with the changes in ISMs physiology and 
development observed at the end of metamorphosis: homeostasis (prior to the onset of 
atrophy), atrophy, committed to die, and actively dying (Schwartz and Ruff, 2002). 
During homeostasis, which lasts until day 15 of the normal 18 days of pupal-adult 
development, the ISMs are intact, fully functional and display a constant mass (Schwartz 
and Truman, 1983). Between days 15 and 18 the ISMs undergo atrophy and lose 40% of 
their mass, which results from decreased expression of the genes that encode contractile 
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Figure 1. Isolated ISMs during different stages of 
development. Prior to day 15, the ISMs are intact and have 
initiated atrophy. Between days 15 and 18 of pupal-adult 
development, the ISMs have undergone atrophy and lost ~40% of 
their mass. On day 18, the ISMs are committed to die and are 
used for adult eclosion. 18 hours post eclosion (PE) there is a 
dramatic loss of muscle mass as the ISMs die.  
proteins as well as enhanced ubiquitin-dependent proteolysis (Schwartz et. al., 1993; 
Schwartz and Ruff, 2002). Following eclosion, the muscles activate a different program 
that results in the complete derangement of the contractile apparatus and the destruction 
of the fibers.  These changes in muscle mass and structure can be readily seen in images 
of the isolated ISMs at different stages of development (Figure 1). 
The ability of the ISMs to die is dependent on de novo gene expression 
(Schwartz et al., 1990a). Between days 17 and 18 there are dramatic changes in the 
patterns of gene expression within the ISMs that coincide with the commitment of the 
cells to die (Schwartz et al., 1990). Some of the primary patterns of differential gene 
expression can be seen via Northern blot analyses for polyubiquitin, the myosin heavy 
chain and small cytoplasmic leucine rich repeat (SCLP) (Figure 2) (Schwartz, 2008). 
While some transcripts are seen to increase, including polyubiquitin, proteasome 
subunits, and Acheron, others are repressed, for example actin and myosin heavy chain 












These changes in transcript abundance predominantly reflect changes in 
transcription. However, there are some intriguing data that suggest that RNA stability 
may also decrease on day 17 (Cascone and Schwartz, 2001). The instability of the RNAs 
may serve to help allow the cell to shift from one developmental program to another by 
removing “housekeeping” transcripts at a time when cell death-associated RNAs are 
being induced. The mechanisms that mediate changes in transcript abundance and 
stability when the ISM transition from atrophy to death programs are poorly understood. 
We have also made the intriguing observation that the abundance of proteasome 
subunits mRNA increases about two-fold from day 16-18, but that the abundance of the 
corresponding protein increases by a couple orders of magnitude. These data suggest 
that there are regulatory controls that impact not only transcript abundance but also 
mRNA translatability. To examine the control of these changes in expression, Cascone 
and Schwartz demonstrated that there were sequences contained within the 3’UTR of 
differentially expressed transcripts that control both transcript abundance and stability 
(Cascone and Schwartz, 2001). While they did not suggest how these sequences are 
controlled, one likely class of regulators are the microRNAs.  
Figure 2. Northern blot of developmentally regulated 
genes during ISM development.  The myosin heavy 
chain is one of the major contractile proteins. Its 
expression declines during atrophy. During ISM atrophy 
and death, there is a dramatic induction of SCLP and 
polyubiquitin on day 18 when the muscle is committed to 
die. However, the majority of genes are not differentially 
expressed, including the Ubf-80 (ubiquitin fusion 80 
gene), which is constitutively expressed. A decline in the 
serum levels of 20 hydroxyecdysone hormone (20E) 
triggers the changes in gene expression, therefore when 





MicroRNAs (miRNAs) are small (~22 nucleotide) non-coding RNAs that bind to 
specific sequences within mRNAs and regulate their stability and translatability (Bartel, 
2009). MicroRNAs can act to cause translational arrest through blocking translational 
initiation, deadenylation of the poly(A+) tail, or recruitment of translational blockers 
(Ameres and Zamore, 2013). They also bind to mRNAs in unique ways. There does not 
need to be complete complementarity between miRNAs and their mRNA targets to 
mediate regulation. Instead, there are seed regions that are located at nucleotides 2-8 
from the miRNA 5’ region, where miRNAs and mRNAs are complementary (Zhang et 
al., 2013). Partial complementarity results in translational arrest, while extensive 
complementarity results in mRNA degradation (Hutvagner and Zamore, 2002). Even if 
the mRNA is not completely complementary to the seed regions, binding at the centered 
site regions located at nucleotides 4-15 and 5-15 from the 5’ region, can also cause 
translational repression (Zhang et al., 2013). The 3’ supplementary sites of miRNA 
nucleotides 12-16 can also enhance mRNA repression via miRNA binding to the mRNA 
target (Ameres and Zamore, 2013). Because multiple miRNA binding sites can be found 
within the same transcript, it is possible for one or a few miRNAs to regulate major 
developmental pathways in cells, such as mitosis (Bartel, 2009). Consequently, miRNAs 
may also provide tools for both diagnostics and therapeutics for many diseases (Van 
Rooij and Olson, 2007).  
To test the hypothesis that miRNAs regulate cell death associated transcripts in 
the ISMs, I have selected four of the conserved genes that are induced when the ISMs 
become committed to die on day 18: Ubiquitin Carboxyl-Terminal Hydrolase 7 (UCH-
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7), Acheron, Trip-1/SUG1, and small cytoplasmic leucine rich repeat protein (SCLP). 
UCH-7 cleaves polyubiquitin chains and serves to increase the pool of free ubiquitin 
monomer within cells, which in turn helps facilitate protein degradation (He et al., 
2014). Acheron is a survival protein that helps coordinate the timing of ISM death 
(Valavanis et al., 2007). The Trip-1/SUG1 protein is an ATPase located in the 19S cap 
of the 26S proteasome, and it helps unwind proteins for ubiquitin-dependent degradation 
(McKenna et al., 2013). SCLP contains leucine rich repeats and is a death-associated 
protein although its function in atrophy and death have yet to be defined (Keulzer et al., 
1999).  
By studying miRNA regulation of mRNA function we will not only generate 
new insights into the molecular mechanisms controlling skeletal muscle atrophy and 
death, but also possible targets for therapeutic interventions or diagnostics. For example, 
by determining the miRNA levels during the four developmental stages in which the 
ISMs undergo (homeostasis, atrophy, committed to die, and actively dying) as explained 
above, the miRNA levels might be useful for classifying which developmental stage the 






Genes of interest 
To gain a better understanding of the control of transcript stability and 
translatability of genes that are induced when the ISMs of Manduca become committed 
to die on day 18 of development, we chose to analyze UCH-7, Acheron, Trip-1/SUG1, 
and SCLP (Figure 3).  The developmentally regulated miR-2765 has seed regions that 
are partially complementary to the target regions in the 3’UTRs of UCH-7; the 
developmentally regulated miR-308 has seed regions completely complementary to the 
target regions in the 3’UTRs of Acheron (Figure 4). Another developmentally regulated 
miRNA, miR-2767, has seed regions completely complementary to the target regions in 
the 3’ UTR of Trip-1/SUG1, and miR-92b has seed regions completely complementary 
to the target regions in the 3’UTR of SCLP (Figure 4). Preliminary data from the 
Schwartz lab supports the hypothesis that these miRNAs may be key regulators of 
atrophy and death in the ISMs. 
The expression levels of miR-2765 and UCH-7, miR-2767 and Trip-1/SUG1, 
and miR-92b and SCLP are inversely related (Figure 3). While miR-2767 levels sharply 
decrease between days 13 to 18 of pupal-adult development, mRNA levels of Trip-
1/SUG1 (Figure 3a) increase between days 13 to 18 with the highest level on day 18 
shown by the peak in the curve. The same is seen in comparing the levels of miR-2765 
with mRNA levels of UCH-7 (Figure 3b), and for comparing the levels of miR-92b and 
SCLP (Figure 3d). When comparing the mRNA level of Acheron with miR-308 levels 
(Figure 3c), no inverse relationship is observed. These data are consistent with the 




Figure 3. Comparing mRNA and miR levels during ISM development and death. The 
graphs on the left show the miR levels depicted as reads per million (rpm) vs the day of 
ISM development (day 13-day 18). The graphs on the right showing the mRNA levels 
depict reads per kilobase per million reads (RPKM) vs the day of ISM developmental (day 
13-day 18 plus 1-hr post-eclosion (PE). The graphs on the left depict: (a) miR-2767 levels, 
(b) miR-2765 levels, (c) miR-308 levels, and (d) miR-92b levels during development. The 
graphs on the right depict mRNA levels of the four proteins of interest: (a) Trip-1/SUG1; 
(b) UCH-7; (c) Acheron; (d) SCLP.  
 
 
Analysis of Plasmid Constructs and miR targets 
Using a bioinformatics approach, putative mRNA targets for the test miRs were 
identified (Figure 4) and their 3’ untranslated region (UTR) were cloned into the pFila 
plasmid. The putative 22bp mRNA targets were also synthesized and cloned into the 
pFila plasmid. This plasmid was constructed in such a way that the Manduca 3’UTR 
was cloned downstream of the luciferase gene from the sea pen Renilla seen in the pFila 
map (Figure 5).  The plasmid map was generated via SnapGene Viewer (from GSL 










3’ CGUCCGGCCCUAACCACGUUAA 5’ 




3’ UUUCGGCGUGCUCUAAAUGAAC 5’ 




3’ CGGUUGCCACCACCUCAAUGGU 5’ 




3’ GAGCGUCAUAAUAGGACACUAA 5’ 









Figure 5. Map of pFila plasmid. The plasmid is constructed in such a way that the 
Manduca 3’UTR of interest was cloned downstream of the luciferase gene from the sea pen 
Renilla. There is also a second constitutively expressed luciferase gene from the firefly. 
Since both luciferase genes are expressed from the same plasmid within the cell, this is a 
very robust way to normalize the signal and know what changes are due to the test 3’UTR 




Figure 4. MicroRNA putative binding sites. The miRNA targets sites in the 3’UTR of the 
transcripts were predicted using TargetScan 6.0. The figure shows the miRNA sequences (miR-
92b, miR-2767, miR-2765, or miR-308) and their putative mRNA binding sites (SCLP, Trip-
1/SUG1, UCH-7, or Acheron). The nucleotides highlighted in yellow indicate mRNA regions 
complementary to the miRNA seed regions. The blue highlighted regions are miRNA 





Trip-1/SUG1 protein expression 
Using Western blotting we observed that Trip-1/SUG1 expression increases 
dramatically during day 18 of development when the muscle is committed to die, 
continuing onto 19 hours post-eclosion (Figure 6). The molecular weight of Trip-











Figure 6. Trip-1/SUG1 protein expression during ISM development. ISM protein 
(15 ug) was fractionated by SDS PAGE and used to generate a Western blot that was 
probed with an anti-Manduca Trip-1/SUG1. The ECL Western blotting detection system 
and X-ray film was used to visualize the reaction.  
 
Analysis of luciferase activity 
 UCH-7 
After the COS-1 cells were co-transfected with the engineered constructs and the 
miRNAs of interest, the cells were assayed to quantify the relative luciferase activity, 
with and without treatment with miRNAs. Five pFila constructs with different inserts 
were used when testing each gene of interest.  The constructs names for UCH-7 are as 
follows: 1) UCH7-WT, which has a synthesized 45 nucleotide insert containing the 
UCH-7 putative miR-2765 binding site; 2) UCH7-3’UTR, which has a ~460 bp insert 
amplified from 3’UTR; 3) UCH7-siRNA, which has a synthesized 45 nucleotide insert 
that contains a completely complementary miR-2765 binding site and serves as an 





5) UCH7-Mutant, which has a synthesized 45 nucleotide insert containing the UCH-7 
putative binding site for miR-2765 but with a mutated seed region, which serves as a 
negative control.  
When the cells were co-transfected with UCH7-WT, UCH7-3’UTR, empty pFila 
vector, and UCH7-Mutant constructs and 1µl of 20nM miR-2765, an increase in 
luciferase activity was observed, however, it is not statistically significant (Figure 7). 
When UCH7-siRNA was treated with 1µl of 20nM miR-2765, the relative luciferase 






For Acheron, five constructs were also designed to determine if Acheron is post 
transcriptionally regulated by miR-308. The constructs names for Acheron are as 
follows: 1) ACH-WT, which has a synthesized 45 nucleotide insert containing the 
Acheron putative miR-308 binding site; 2) ACH-3’UTR, which has a ~850bp insert 









































































Figure 7. UCH-7 is not post-
transcriptionally regulated by 
miR-2765. The normalized relative 
luciferase activity (Renilla/firefly) of 
the UCH-7 constructs when treated 
with miR-2765 were graphed. The 
relative luciferase activity was 
compared after co-transfection of 
COS-1 cells with the construct 
(UCH7-WT, UCH7-3’UTR, UCH7-
siRNA, empty pFila vector, or 
UCH7-Mutant) and 1µl of 20nM 
miR-2765. The student’s T-test was 
used to test statistical significance. 
The red bars represent the results 
using the experimental constructs 
and the green bars represent the 





completely complementary to miR-308 and serves as a positive siRNA control; 4) empty 
pFila vector, which serves as a negative control; and 5) ACH-Mutant, which has a 
synthesized 45 nucleotide insert containing the presumptive Acheron miR-308 binding 
site but is mutated in the seed region serving as a negative control.  
 
         
 
      
When the cells were co-transfected with ACH-Mutant and 1µl of 20nM miR-
308, an increase in luciferase activity was observed (Figure 8). When the cells were co-
transfected with ACH-WT and 1µl of 20nM miR-308, an increase in luciferase activity 
was observed and was found to be statistically significant (Figure 8). When the cells 
were co-transfected with the empty pFila vector and 1µl of 20nM miR-308, an increase 
in luciferase activity was observed and was found to be statistically significant as well 
(Figure 8). The Acheron/miR-308 siRNA experiment resulted in a 0.93 decrease in 
luciferase activity to 0.07, which was statistically significant (Figure 8). When ACH-
3’UTR was co-transfected with 1µl of 20nM miR-308, the relative luciferase activity 












































































Figure 8. Acheron is not post-
transcriptionally regulated by miR-308. 
The normalized relative luciferase activity 
(Renilla/ firefly) of the Acheron constructs 
when treated with miR-308 were graphed. 
The relative luciferase activity was 
compared after co-transfection of COS-1 
cells with the construct (ACH-WT, ACH-
3’UTR, ACH-siRNA, empty pFila vector, 
or ACH-Mutant) and 1µl of 20nM miR-
308. The student’s T-test was used to test 
statistical significance. The red bars 
represent the results using the experimental 
constructs and the green bars represent the 






For Trip-1/SUG1, five constructs were also designed to determine if Trip-
1/SUG1 is post transcriptionally regulated by miR-2767. The constructs names for Trip-
1/SUG1 are as follows: 1) SUG1-WT, which has a synthesized 45 nucleotide insert 
containing the presumptive Trip-1/SUG1 miR-2767 binding site; 2) SUG1-3’UTR, 
which has a ~600bp insert amplified from the 3’ UTR; 3) SUG1-siRNA, which has a 
synthesized 45 nucleotide insert completely complementary to miR-2767 and serves as 
an siRNA positive control; 4) empty pFila vector, which serves as a negative control; 
and 5) SUG1-Mutant, which has a 45 nucleotide insert containing the presumptive miR-
2767 Trip-1/SUG1 binding site but with a mutation in the seed region, which serves as a 
negative control.  
When the empty pFila vector was co-transfected with 1µl of 20nM miR-2767, an 
increase in luciferase activity was observed (Figure 9). When SUG1-WT was co-
transfected with 1µl of 20nM miR-2767, the relative luciferase activity decreased by 0.2 
to 0.80 (Figure 9). When SUG1-3’UTR, SUG1-siRNA, and SUG1-Mutant were co-
transfected with 1µl of 20nM miR-2767, the relative luciferase activity decreased 0.03 to 
0.97, 0.82 to 0.18, and 0.08 to 0.92 respectively (Figure 9). The decrease in luciferase 
activity was found to be statistically significant only when SUG1-WT and Sug1-siRNA 








For SCLP, five constructs were also designed to determine if SCLP is post- 
transcriptionally regulated by miR-92b. The constructs names for SCLP are as follows: 
1) SCLP-WT, which has a synthesized 45 nucleotide insert containing the SCLP 
putative binding site for miR-92b; 2) SCLP-3’UTR, which has a ~400bp insert amplified 
from ISM cDNA; 3) SCLP-siRNA, which has a synthesized 45 nucleotide insert 
completely complementary to miR-92b and serves as a positive control; 4) empty pFila 
vector, which serves as a negative control; and 5) SCLP-Mutant, which has a 45 
nucleotide insert containing the SCLP putative binding site for miR-92b but is mutated 
in the seed region serving as a negative control.  
When SCLP-WT, empty pFila vector, and SCLP-Mutant were treated with 1µl 
of 20nM miR-92b, an increase in luciferase activity was observed (Figure 10). When 
SCLP-3’UTR and SCLP-siRNA were treated with 1µl of 20nM miR-92b, the relative 
luciferase activity decreased 0.38 to 0.62 and 0.78 to 0.22 respectively and was found to 










































































Figure 9. Trip-1/Sug1 may be post-
transcriptionally regulated by miR-2767. The 
normalized relative luciferase activity (Renilla/ 
firefly) of the Trip-1/SUG1 constructs when 
treated with miR 2767 were graphed. The 
relative luciferase activity was compared after 
co-transfection of COS-1 cells with the 
construct (SUG1-WT, SUG1-3’UTR, SUG1-
siRNA, empty pFila vector, or SUG1-Mutant) 
and 1µl of 20nM miR-2767. The student’s T-
test was used to test statistical significance. The 
red bars represent the results using the 
experimental constructs and the green bars 






       Quantitative PCR 
Quantitative PCR was used to determine if miR-92b affects the stability of SCLP 
mRNA. Renilla expression was normalized to firefly expression and only the constructs 
SCLP-siRNA and SCLP-3’UTR were used (Figure 11). The COS-1 cells were co-
transfected like before with 1µl of 20nM miR-92b and SCLP-siRNA or SCLP-3’UTR. 
The COS-1 cells were also transfected with only SCLP-siRNA or SCLP-3’UTR and 
compared to the co-transfection experiment. For SCLP-siRNA with miR-92b, gene 
expression was observed decreasing 69.30% to 30.90% and was statistically significant 
(Figure 11). For SCLP-3’UTR with miR-92b, gene expression increased 21.59% but the 









































































Figure 10. SCLP may be post-
transcriptionally regulated by miR-92b. 
The normalized relative luciferase activity 
(Renilla/firefly) of the SCLP constructs when 
treated with miR-92b were graphed. The 
relative luciferase activity was compared 24 
hours after co-transfection of COS-1 cells 
with the construct (SCLP-WT, SCLP-3’UTR, 
SCLP-siRNA, empty pFila vector, or SCLP-
Mutant) and 1µl of 20nM miR-92b. The 
student’s T-test was used to test statistical 
significance. The red bars represent the 
results using the experimental constructs and 
























Figure 11.  miR-92b has no effect on the 
transcript stability of SCLP. miR-92b was co-
transfected with either SCLP siRNA, a vector with 
a 3'UTR target site completely complementary to 
miR-92b, or SCLP 3’UTR, a vector with a 3'UTR 
target site amplified from ISM cDNA. After 24 
hours, the cells were lysed and Renilla luciferase 
expression was measured using SYBR Select 
Master Mix (Applied Biosystems by Life 
Technologies, Carlsbad, CA). Renilla expression 
was normalized to firefly expression and relative 
mRNA levels were compared using the ∆∆Ct- 





Discussion and Implications for Future Research 
The molecular mechanisms that regulate programmed cell death during 
development are poorly understood. It is known that cell death is dependent on de novo 
gene expression of death-associated transcripts (Schwartz et al., 1990a) and these genes 
have been examined in detail.  While many of these changes in gene expression are 
controlled at the level of transcription, this does not fully account for the changes in 
gene expression at the protein level.  For example, the abundance of the Trip-1/SUG1 
mRNA changes two fold between days 17 and 18, rising from 400 RPKM to 800 RPKM 
(Figure 3a) while the change in protein abundance during that same period increases 
more than an order of magnitude (Figure 6).  One possible mediator of this discrepancy 
are microRNAs, small interfering RNAs that can block expression post-transcriptionally 
by blocking translation or facilitating the degradation of target mRNAs (references).  
Earlier data from the Schwartz lab provided data that is consistent with this hypothesis.  
They found that there were developmental changes in transcript stability and 
translatability and that these properties were mediated by sequences within the 3’ UTR 
of ISM genes (Cascone and Schwartz, 2001). However, since they did not evaluate a 
possible role for miRs Consequently, the focus of my thesis was to directly test this 
hypothesis. We found that several miRs are developmentally regulated and either 
declined during ISM development or increased.  I chose to focus on the latter since their 
loss could de-repress transcript expression.  As examples, miR-2767 progressively 
declines during ISM atrophy and death, with the lowest levels on day 17 and day 18 of 
development (Figure 3a), while miR-92b declines dramatically on day 14 (Figure 3d).  




To functionally test the hypothesis that these developmentally regulated miRs 
alter the stability or translatability of target mRNAs, I created a series of expression 
constructs that placed miR target sequences 3’ to the Renilla luciferase gene in the pFila 
vector. The vector, with or without the appropriate miR were transfected into COS-1 
cells and the subsequent luciferase activity was measured. For each gene studied, I 
included a vector that contained a sequence that shared 100% complementarity to the 
miR under investigation, which served as an siRNA positive control. While all of the 
test miRs display 100% complementary to their putative mRNA targets within the seed 
region (highlighted in yellow in Figure 4), I did not anticipate that they would alter 
transcript stability because there is little significant complementarity outside of the seed 
region (Figure 4).  
The functional tests of the pFila vector were successful and I was able to 
independently detect both Renilla and firefly luciferase activities. However, the results I 
obtained from measuring the effects of miRNA treatment on the target 3’ UTRs 
provided variable results.  I expected to observe a decrease in luciferase activity when 
the cells were treated with the test miRNAs; however, I only observed a statistically 
significant decrease in luciferase activity for Trip-1/SUG1 and SCLP (Figure 9 and 10).  
I found that miR-2765 did not induce a decrease in luciferase activity when the 
cells were co-transfected with UCH-7 engineered constructs. The only decrease in 
luciferase expression I observed was when the COS-1 cells were co-transfected with 
UCH7-siRNA, which has a sequence completely complementary to miR-2765 and acts 
as an siRNA positive control (Figure 7).  As expected, I also observed that miR-2765 




negative controls: the empty pFila vector or the mutant miR target sequence, UCH7-
Mutant (Figure 7). Likewise, miR-2765 did not cause a decrease in luciferase activity 
when the COS-1cells were co-transfected with the experimental constructs UCH7-WT 
or UCH7-3’UTR, which contains the putative mRNA targets for miR-2765 (Figure 7). 
Therefore, I conclude that miR-2765 alone does not repress the translatability or stability 
of the target UCH-7 mRNA because I did not observe a decrease in luciferase activity 
for our experimental UCH-7 constructs. However, there is a possibility that miR-2765 
might act in concert with another miRNA(s) to synergistically induce a decline in the 
translatability and stability of the target mRNA.  
In a separate co-transfection experiment using the construct with the Acheron 
3’UTR insert and miR-308 gave a surprising result. I observed a statistically significant 
increase in luciferase activity when the cells were co-transfected with ACH-WT and 
miR-308 (Figure 8).  However, when I co-transfected the cells with an empty pFila 
vector, which served as our negative control, I also observed an increase in luciferase 
activity (Figure 8). Therefore, I believe that miR-308 does not have an effect on the 
translatability or stability of Acheron mRNA because there was an increase in luciferase 
activity when the cells were co-transfected in both our experimental and control 
experiments (Figure 8). However, as mentioned before, there is the possibility that I did 
not see the expected decrease in luciferase activity because miR-308 only functions 
combinatorially with other miRs on the Acheron mRNA. For my siRNA control with 
ACH-siRNA and miR-308, I observed the anticipated decrease in luciferase activity 




For my third set of co-transfection experiments testing Trip-1/SUG1 and miR-
2767, I observed a statistically significant decrease in luciferase activity by 0.2 or 20% 
when I co-transfected my cells with SUG1-WT, the construct with the synthesized 
putative mRNA binding site for miR-2767, and miR-2767 (Figure 9).  I observed the 
anticipated statistically significant decrease in luciferase activity by 0.82 for our positive 
siRNA control, SUG1-siRNA, when co-transfected with miR-2767 as expected (Figure 
9). I did not see a statistically significant decrease in luciferase activity when SUG1-
3’UTR, which has the ~600bp 3’ UTR insert, was co-transfected with miR-2767, which 
may be because miR-2767 has to work in concert with another miR to cause a decrease 
in the transcript stability and translatability of Trip-1/Sug1 mRNA (Figure 9). Therefore, 
we conclude that miR-2767 may affect the translatability of Trip-1/SUG1 mRNA. This 
agrees with our observation of the dramatic increase in Trip-1/SUG1 protein expression 
seen on the Western blot during through ISM development (Figure 6) and the decrease 
in miR-2767 levels during atrophy and the commitment to die (Figure 3). 
My final gene of interest was SCLP. In contrast to the previous experiments, I 
observed a decrease in luciferase activity when I co-transfected the cells with SCLP-
3’UTR, which has the amplified putative mRNA binding site from ISM cDNA, and 
miR-92b (Figure 10). However, we did not observe a decrease in luciferase activity 
when we co-transfected our cells with SCLP-WT, which has the synthesized putative 
mRNA binding site, which was not expected (Figure 10).  One possible reason that may 
account for the observed the 38% decrease in luciferase activity is the difference in 
insert size between the two constructs. SCLP-WT has a 45bp insert, while SCLP-3’UTR 




structural context for proper miR-92b binding, thus we did not see a decrease in 
luciferase expression for SCLP-WT. (Figure 10). I saw the anticipated decrease in 
luciferase activity when I co-transfected our cells with our positive siRNA control 
SCLP-siRNA, and no difference in luciferase activity when I co-transfected our cells for 
our negative controls empty pFila vector or the SCLP-Mutant, as expected (Figure 10).  
I wanted to determine if miR-92b-dependent repression in expression was due to 
effects on transcript translatability or stability, so I employed qPCR to quantify mRNA 
levels.   I tested SCLP-siRNA as a positive siRNA control and SCLP- 3’UTR as the 
experimental construct, where I previously observed a 38% decrease in luciferase 
activity (Figure 10). miR-92b treatment resulted in a 69.30% decrease in transcript 
abundance for SCLP-siRNA, as expected (Figure 11). However, I did not detect a 
decrease in gene expression of the SCLP-3’UTR when the cells were co-transfected with 
SCLP-3’UTR and miR-92b (Figure 11). I interpreted these data as suggesting that while 
miR-92b blocks SCLP translation, it does not alter transcript stability (Figure 11).   
It should be noted that miR-92b is of interest for our study because it has a 
suggested role in several clinical disorders and a demonstrated regulatory role in 
apoptosis (Li et al., 2013). miR-92 was found to be highly expressed in high-grade 
gliomas, an aggressive form of brain tumor (Li et al., 2013).  In these tumors, miR-92 
was observed to increase glioma cell proliferation and repress apoptosis in glioma (Li et 
al., 2013). When the cells were treated with a miR-92 inhibitor, the level of apoptosis 
was increased (Li et al., 2013). To offer more support to the role of miR-92 in apoptosis, 
the miR-92 family was also found to have a role in regulating the mitochondrial 




BH3-only protein (Pernaute et al., 2014). miR-92 has clinical significance in human 
muscle disorders as well, as it was found to be repressed in idiopathic dilated 
cardiomyopathy and ischemic cardiomyopathy, two types of heart failure (Sucharov et 
al., 2008).  
In the future, the lab plans to advance to in vivo experiments using the Manduca 
embryo GV1 cell line (Lan et al., 1997). By using GV1 cells, we can determine the 
functional interaction between ISM miRNAs and mRNAs in vivo. We already know that 
GV1 cells express Acheron, and assume that they express proteasome subunits (Trip-
1/Sug1) and likely express UCH-7 as well. It is unknown if they also express SCLP. We 
also hope to perform combinatorial microRNA experiments using multiple microRNAs 
to test if multiple microRNAs can have a greater effect in blocking translation or 
decreasing the transcript stability of our target transcripts. 
By determining the functional interaction between miRNAs and mRNAs in the 
ISMs, we can gain a better understanding about the regulation of skeletal muscle atrophy 







Materials and Methods 
Western Blot 
To determine the Trip-1/SUG1 protein expression in the ISMs during 
development, tissue was collected from Manduca during day 13 to day 18 of 
development, 4 and 19 hours post-eclosion. Proteins were extracted in Laemlli buffer 
and 15 ug of each sample were fractionated via gel electrophoresis using a 12% Mini-
PROTEAN® TGX™ polyacrylamide gel (Bio-Rad, Hercules, California). Following 
electrophoresis, the proteins were electrophoretically transferred to Immobilon-P (EMD 
Millipore) and reacted with a rabbit anti-Trip-1/Sug1 antibody (named 18-56) (Sun et 
al.,1996) at a 1:2000 dilution followed by detection with goat anti-rabbit antibody 
(Jackson ImmunoResearch).  The Western Lightning™ Plus-ECL, Enhanced 
Chemiluminescence Substrate (PerkinElmer, Waltham, MA) and X-ray film was used 
for protein detection. 
 
Engineering constructs 
 Regions of the target mRNAs containing putative miRNA binding sites were 
subcloned into the pFila vector.  ISM RNA (provided by C. Brown in the Schwartz lab) 
was used to synthesize the cDNA using reverse transcriptase PCR (RT-PCR). To 
perform RT-PCR, Superscript III First-Strand Synthesis System (Invitrogen, Carlsbad, 
CA) was used. Primers were then designed that would amplify the miR-2765 and miR-
308 target regions in Acheron, the miR-2765 target region in UCH-7, the miR-2767 and 
miR-6096 target regions in Trip-1/SUG1, and the miR-92b target region in SCLP 
(presented below). The miRNA targets sites in the 3’UTR of the transcripts were 




online Integrated DNA Technologies PrimerQuest software (Coralville, IA) and a 
vector-specific sequence was added onto the 5’ end of the primers using In-Fusion 
Primer Design (Clontech, Mountain View, CA). Primers were then ordered through 
Integrated DNA technologies (Coralville, IA). The primers used for subcloning the 
3’UTR insert of Acheron into the pFila vector were 5’-
GAACAATAATTCTAGAGTTGGACAGTGCGAATGTTTAG- 3’ and 5’- 
AAGCGGCCGCTCTAGGGCCCACGAGTGCGACGAAAGTATAG- 3’.  The primers 
used for subcloning the 3’UTR insert of UCH-7 into the pFila vector were 5’-
GAACAATAATTCTA GAGCGCGTTGTATAGGGTGATAA- 3’ and 5’-
AAGCGGCCGCTCTAGGGCCCCCGAACT AAACAGGGCAGAA-3’. The primers 
used for subcloning the 3’UTR insert of Trip-1/SUG1 into the pFila vector were 5’-
GAACAATAATTCTAGGCATAACACAGTCCCTGCATAA-3’ and 5’- 
AAGCGGCCGCTCTAGGCCATGTCATAACCAACACAAAG-3’. The primers used 
for subcloning the 3’UTR insert of SCLP into the pFila vector were 
5’GAACAATAATTC TAGTCTCTATGGACTAAGCCTGTGA 3’ and 5’ 
AAGCGGCCGCTCTAGGACACTT AACATAACATCCCAAACC 3’. I refer to these 
constructs as gene name-3’UTR, hence (ACH-3’UTR, UCH7-3’UTR, SUG1-3’UTR, 
and SCLP-3’UTR).  
The miRNA 3’UTR target regions were amplified via the polymerase chain 
reaction (PCR) with the conditions as follows: 30 cycles of (98°C for 10 seconds, 55°C 
for 15 seconds, and 72°C for 1 minute).  The resulting PCR products were purified using 
the NucleoSpin Gel and PCR Clean-Up Kit (Clontech, Mountain View, CA).  The pFila 




ApaI from New England Biolabs (Ipswich, MA). Next, the target 3’ UTR regions of 
Acheron, UCH-7, Trip-1/SUG1, and SCLP were subcloned into the linearized pFila 
using the In-Fusion® HD Cloning Kit (Clontech, Mountain View, CA), producing three 
constructs containing the Manduca 3’ UTR located downstream of the Renilla luciferase 
gene. 
Four additional constructs were generated that contained the 22-nucleotide 
sequence in the 3’UTR that served as the miRNA target for each gene, which was 
synthesized by Integrated DNA Technologies (Coralville, IA). The synthesized regions 
of the target mRNAs containing putative miRNA binding sites were subcloned into the 
pFila vector.  Each insert was synthesized with a 5’ XbaI sticky end and a 3’ ApaI sticky 
end. An EcoRI restriction site was also inserted into each synthesized insert to confirm 
that the insert was successfully subcloned into the pFila vector. For the miR- 92b target 
in the SCLP 3’UTR the synthesized sense strand was 5’ CTAGATAGAATTCTA 
GTGTAAGGTCCCTATAGTGCAATTGGGCC 3’, and the synthesized antisense 
strand was 3’TATCTTAAGATCACATTCCAGGGATATCAC GTTAAC 5’. For the 
miR-2767 target in the Trip-1/SUG1 3’ UTR, the synthesized sense strand was 5’ 
CTAGATAGAATTCTAGTACTAAATGA CTCATTTTACTTAGGGCC 3’ and the 
synthesized antisense strand was 3’ TATCTTAAGATCATGATTTACTGAGTAA 
AATGAATC 5’.  For the miR-308 target in the Acheron 3’ UTR, the synthesized sense 
strand was 5’ CTAGATAGAATTCT GTCGACTCTGCCTCGACTGTGATAGGGCC 
3’ and the synthesized antisense strand was 3’ TATCTTAAGATCAGCTGAG 
ACGGAGCTGACACTATC 5’. For the miR-2765 target in the UCH7 3’ UTR, the 




ATTGTCGAATTACCAGGGCC 3’ and the antisense strand was 3’ TAT 
CTTAAGATCAAAGTTACTAACAGCTTAATGGTC 5’.  I refer to these constructs as 
gene name-WT, hence (ACH-WT, UCH-7-WT, SUG1-WT, and SCLP-WT).  
As a negative control, four mutant constructs were generated containing the 22-
nucleotide sequence in the 3’UTR that served as the miRNA target for each gene, which 
was synthesized by Integrated DNA Technologies (Coralville, IA). In the mutant 
synthesized inserts, three nucleotides located in the mRNA region complementary to the 
miRNA seed region were exchanged from the sense and antisense strand and the middle 
nucleotide was deleted.  The synthesized regions of the target mRNAs containing 
putative miRNA binding sites were also subcloned into the pFila vector.  For the miR- 
92b target in the SCLP 3’UTR the synthesized sense strand was 5’ CTAGATA 
GAATTCTAGTGTAAGGTCCCTATAGTCTATTGGGCC 3’ and the synthesized 
antisense strand was 3’TATCTTAAGATCACATTCCAGGGAT ATCAGATAA C 5’. 
For the miR-2767 target in the Sug1/Trp1 3’ UTR, the synthesized sense strand was 5’ 
CTAGATAGAATTCTAGTACTAAATGACTCATTTAGTTA GGGCC 3’ and the 
synthesized antisense strand was 3’ TATCTTAAGATCATGA 
TTTACTGAGTAAATCAATC  5’.  For the miR-308 target in the Acheron 3’ UTR, the 
synthesized sense strand was 5’ CTAGATAGAATTCTAGTCGACT 
CTGCCTCGACTCCATAGGGCC 3’and the synthesized antisense strand was 3’ 
TATCTTAAGAT CAGCTGAGACGGAGCTGAGGTATC 5’. For the miR-2765 target 
in the UCH-7 3’ UTR, the synthesized sense strand was 5’ CTAGATAGAA 
TTCTAGTTTCAATGATTGTCGAATAGCAGGGCC 3’and the antisense strand was 




constructs as gene name-Mutant, hence (ACH-Mutant, UCH7-Mutant, SUG1-Mutant, 
and SCLP-Mutant).  
In addition, constructs were additionally made that contained a target sequence that 
was 100% complimentary to the 22-nucleotide test miR, which served as an siRNA 
positive control, and then subcloned into the pFila vector. The inserts were synthesized 
by Integrated DNA Technologies (Coralville, IA). For the miR- 92b target in the SCLP 
3’UTR the synthesized sense strand was 5’ CTAGATAGAATTCTAGT 
GCAGGCCGGGATTGGTGCAATTGGGCC 3’ and the synthesized antisense strand 
was 3’ TACTTAAGATCACGTCCGGCCCTAACCACGTT AAC 5’. For the miR-2767 
target in the Sug1/Trp1 3’ UTR, the synthesized sense strand was 5’ CTAGATA 
GAATTCTAGTAAAGCCGCACGAGATTTACTTGGGGCC 3’ and the synthesized 
antisense strand was 3’ TATCTTAAGATCATTTCGGCGTGCTCTAAATGAACC 5’.  
For the miR-308 target in the Acheron 3’ UTR, the synthesized sense strand was 5’ 
CTAGATAGAATTCTAGTCTCGCAGT ATTATCCTGTGATTGGGCC 3’and the 
synthesized antisense strand was 3’ TATCTTAAGATCAGAGCGTCATA 
ATAGGACACTAAC 5’. For the miR-2765 target in the UCH-7 3’ UTR, the 
synthesized sense strand was 5’ CTAGATAGAATTCTAGTGCCAACGGTGGT 
GGAGTTACCAGGGCC 3’and the antisense strand was 3’ TATCTTAAGATCAC 
GGTTGCCACCACCTCAATGGTC 5’. I refer to these constructs as gene name-siRNA, 
hence (ACH-siRNA, UCH7-siRNA, SUG1-siRNA, and SCLP-siRNA).  
 
Transformation of Escherichia coli cells 
The pFila constructs were transformed into Stellar Competent cells, an E.coli 




bacterial colonies were then mini-prepped to extract the plasmid DNA using the 
QIAprep Spin Miniprep Kit (QIAGEN,Valencia, CA). Restriction digestions of the three 
DNA plasmids were then performed to confirm the presence of the anticipated inserts 
and the digestion products were visualized using agarose gel electrophoresis. The 
plasmid with the Acheron 3’UTR was digested with SacII, the plasmid with the UCH-7 
3’UTR was digested with EcoRI, and the plasmid with the Trip-1/SUG1 insert was 
digested with HindIII. The restriction enzymes were all from New England Biolabs 
(Ipswich, MA).  Colony PCR was also used to determine the identity of the inserts. To 
further verify the identity of the inserts, the purified DNA constructs were sent to 
Genewiz for sequencing. The bacterial colonies transformed with the correct insert were 
then maxi-prepped using the EndoFree Plasmid Maxi Kit (QIAGEN, Valencia, CA). 
 
Cell culture, Transfection and Cotransfection of COS-1 cells and Dual Luciferase 
Assay 
COS-1 cells, which are derived from the African green monkey kidney, were 
grown and maintained in high glucose Dulbecco’s Modified Eagle Medium (DMEM) 
(Gibco, Grand Island, NY) with 10% fetal bovine serum (Atlanta Biologicals, Flowery 
Branch, GA) and 1X Penicillin/Streptomycin solution (Gibco, Grand Island, NY). In all 
transfection experiments, 4 x 104 COS-1 cells were seeded the day before transfection. 
In one set of experiments, the COS-1 cells were transfected with 50 ng of plasmid DNA 
(either empty pFila vector, SCLP-WT, SCLP-3’UTR, SCLP-siRNA, SCLP-Mutant, 
SUG1-WT, SUG1-3’UTR, SUG1-siRNA, SUG1-Mutant, ACH-WT, ACH-3’UTR, 
ACH -siRNA, ACH-Mutant, UCH7-WT, UCH7-3’UTR, UCH7-siRNA, UCH7-Mutant) 




In a second set of experiments, the COS-1 cells were co-transfected with 50 ng of DNA 
(either pFila, SCLP-WT, SCLP-3’UTR, SCLP-siRNA, SCLP-Mutant, SUG1-WT, 
SUG1-3’UTR, SUG1-siRNA, SUG1-Mutant, ACH-WT, ACH -3’UTR, ACH -siRNA, 
ACH-Mutant, UCH7-WT, UCH7-3’UTR, UCH7-siRNA, UCH7-Mutant)  and 1µl of 
20µM miRNA (either miR-92b for SCLP constructs, miR-2767 for Trip1/SUG1 
constructs, miR-308 for Acheron constructs, and miR-2765 for UCH-7 constructs) 
ordered from QIAGEN (Valencia, CA) using 2µL of Lipofectamine 2000 transfection 
reagent (Thermofisher, Waltham, MA). All transfections were completed in triplicates. 
The COS-1 cells were collected and lysed 24 hours after transfection with passive lysis 
buffer (Promega, Madison, WI) To observe the effects of miRNA on luciferase gene 
expression, the amount of luciferase activity was quantified using the Dual Luciferase 
Reporter Assay System (Promega, Madison, WI). 
 
Normalizing the Dual luciferase reporter assay 
Transfected cells were analyzed by spectrophotometric plate assays (Hofmann et. 
al., 1999) using the Dual Luciferase Reporter Assay System (Promega, Madison, WI) 
and the POLARstar Optima microplate reader (BMG Labtech, Cary, NC). To normalize 
the data for the reporter assays, the fold change in activity was calculated by 
determining the ratio of Renilla luciferase activity (RLU) to firefly luciferase activity of 
the DNA plasmids following treatment with miRNAs and the ratio of Renilla to firefly 








Total RNA was isolated from transfected COS-1 cells using the RNeasy Mini Kit 
(QIAGEN, Valencia, CA). 100 ng of total RNA was used to synthesize the cDNA using 
RT-PCR. Superscript III First-Strand Synthesis System (Invitrogen, Carlsbad, CA) was 
used to perform RT-PCR. 
         Renilla luciferase expression was measured using SYBR Select Master Mix 
(Applied Biosystems by Life Technologies, Carlsbad, CA).  The Renilla forward primer 
used was 5’ CATGGGATGAATGGCCTGATA 3’ and the Renilla reverse primer used 
was 5’ CAACATGGTTTCCACGAAGAAG 3’. Renilla expression was normalized to 
firefly luciferase mRNA expression using ∆∆Ct- method. The firefly forward primer 
used was 5’ CATAGCTTACTGGGACGAAGAC 3’. The firefly reverse primer used 
was 5’ CCACCTGATAGCCTTTGTACTT 3’.  All experiments were performed with 
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